Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies.

Handoyo V, Pertiwi GAR, Prabawa IPY, Manuaba IBAP, Bhargah A, Budiana IPG.

Int Med Case Rep J. 2019 Feb 8;12:33-38. doi: 10.2147/IMCRJ.S189370. eCollection 2019.

2.

Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol.

Reuben A, Appelboam A, Barton A, Vickery PJ, Body R, Hilton M, Coppell J, Ewings P.

BMJ Open. 2019 Feb 15;9(2):e026882. doi: 10.1136/bmjopen-2018-026882.

3.

Oral tranexamic acid associated with platelet transfusion to prevent hemorrhage in a patient with Glanzmann thrombasthenia.

Félix LC, Moreira MM, Forte Oliveira FA, Fernandes CP, Lima Mota MR, Nunes Alves APN, Sousa FB.

Gen Dent. 2019 Jan-Feb;67(1):61-65.

PMID:
30644834
4.

Tranexamic acid for patients with nasal haemorrhage (epistaxis).

Joseph J, Martinez-Devesa P, Bellorini J, Burton MJ.

Cochrane Database Syst Rev. 2018 Dec 31;12:CD004328. doi: 10.1002/14651858.CD004328.pub3.

PMID:
30596479
5.

Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis.

Gottlieb M, DeMott JM, Peksa GD.

Ann Pharmacother. 2018 Dec 21:1060028018820625. doi: 10.1177/1060028018820625. [Epub ahead of print]

PMID:
30577703
6.

Epistaxis.

Krulewitz NA, Fix ML.

Emerg Med Clin North Am. 2019 Feb;37(1):29-39. doi: 10.1016/j.emc.2018.09.005. Review.

PMID:
30454778
7.

Topical use of tranexamic acid for the management of post-procedural rectal bleeding.

Altawil Z, Gendron BJ, Schechter-Perkins EM.

Am J Emerg Med. 2019 Jan;37(1):173.e3-173.e4. doi: 10.1016/j.ajem.2018.09.037. Epub 2018 Sep 25.

PMID:
30343959
8.

Glanzmann's Thrombastenia: The Role of Tranexamic Acid in Oral Surgery.

Franco R, Miranda M, Di Renzo L, De Lorenzo A, Barlattani A, Bollero P.

Case Rep Dent. 2018 Sep 5;2018:9370212. doi: 10.1155/2018/9370212. eCollection 2018.

9.

Topical tranexamic acid for the treatment of epistaxis in patients using antiplatelet agents.

Sanderson M, Powell J, Lang E.

CJEM. 2018 Sep;20(5):774-776. doi: 10.1017/cem.2018.422.

PMID:
30205859
10.

Topical tranexamic acid for the treatment of acute epistaxis in the emergency department.

Birmingham AR, Mah ND, Ran R, Hansen M.

Am J Emerg Med. 2018 Jul;36(7):1242-1245. doi: 10.1016/j.ajem.2018.03.039. Epub 2018 Mar 21.

PMID:
29602670
11.

Post-turbinectomy nasal packing with Merocel versus glove finger Merocel: A prospective, randomized, controlled trial.

Abu Eta R, Eviatar E, Pitaro J, Gavriel H.

Ear Nose Throat J. 2018 Mar;97(3):64-68.

PMID:
29554399
12.

Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED?

Hassen GW, Clemons P, Kaplun M, Kalantari H.

Am J Emerg Med. 2018 Apr;36(4):734.e1-734.e2. doi: 10.1016/j.ajem.2018.01.020. Epub 2018 Jan 4.

PMID:
29310981
13.

Haematological factors in the management of adult epistaxis: systematic review.

Williams A, Biffen A, Pilkington N, Arrick L, Williams RJ, Smith ME, Smith M, Birchall J.

J Laryngol Otol. 2017 Dec;131(12):1093-1107. doi: 10.1017/S0022215117002067. Review.

PMID:
29280698
14.

Topical Tranexamic Acid Compared With Anterior Nasal Packing for Treatment of Epistaxis in Patients Taking Antiplatelet Drugs: Randomized Controlled Trial.

Zahed R, Mousavi Jazayeri MH, Naderi A, Naderpour Z, Saeedi M.

Acad Emerg Med. 2018 Mar;25(3):261-266. doi: 10.1111/acem.13345. Epub 2017 Dec 9.

15.

BET 1: Tranexamic acid in epistaxis: who bloody nose?

Penrose N, May G.

Emerg Med J. 2016 Nov;33(11):823-825. doi: 10.1136/emermed-2016-206351.1. Review.

PMID:
28319931
16.

Guidelines of the French Society of Otorhinolaryngology (SFORL) (short version). Specific treatment of epistaxis in Rendu-Osler-Weber disease.

Robard L, Michel J, Prulière Escabasse V, Bequignon E, Vérillaud B, Malard O, Crampette L; SFORL Work-Group.

Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Feb;134(1):37-41. doi: 10.1016/j.anorl.2016.09.010. Epub 2016 Dec 14. Review.

17.
18.

Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.

Whitehead KJ, Sautter NB, McWilliams JP, Chakinala MM, Merlo CA, Johnson MH, James M, Everett EM, Clancy MS, Faughnan ME, Oh SP, Olitsky SE, Pyeritz RE, Gossage JR.

JAMA. 2016 Sep 6;316(9):943-51. doi: 10.1001/jama.2016.11724.

PMID:
27599329
19.

A systematic review of anti-thrombotic therapy in epistaxis.

Musgrave KM, Powell J.

Rhinology. 2016 Dec 1;54(4):292-391. doi: 10.4193/Rhin16.040. Review.

PMID:
27591836
20.

A Patient With Pancytopenia, Intractable Epistaxis, and Metastatic Prostate Cancer: How Correct Diagnosis of Primary Hyperfibrinolysis Helps to Stop the Bleeding.

Jafri MA, Cohen JV, Much MA, Petrylak DP, Podoltsev NA.

Clin Genitourin Cancer. 2016 Oct;14(5):e545-e548. doi: 10.1016/j.clgc.2016.05.002. Epub 2016 May 27. No abstract available.

PMID:
27320762

Supplemental Content

Loading ...
Support Center